Molecular epidemiology of HCV genotypes among injection drug users in taiwan: Full-length sequences of two new subtype 6w strains and a recombinant form-2b6w

Journal of Medical Virology

Volumn 82, Issue 1, 2010, Pages 57-68

  Lee, Yuan Ming ^a,b   Lin, Huang Jie ^a   Chen, Yen Ju ^a   Lee, Cheng Ming ^a   Wang, Sheng Fan ^a   Chang, Kai Yuan ^a   Chen, Tzu Lang ^a   Liu, Hsin Fu ^c   Chen, Yi Ming Arthur ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b SAINT PAUL S HOSPITAL   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

HCV genotypes; Human immunodeficiency virus type 1; Injection drug users

Indexed keywords

NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 3;

ARTICLE; CHINA; DRUG DEPENDENCE; GENETIC RECOMBINATION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MIXED INFECTION; MOLECULAR EPIDEMIOLOGY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TAIWAN; THAILAND; UNINDEXED SEQUENCE; VIRUS RECOMBINANT; VIRUS STRAIN;

GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR EPIDEMIOLOGY; NUCLEIC ACID HYBRIDIZATION; PHYLOGENY; POLYMERASE CHAIN REACTION; QUESTIONNAIRES; RECOMBINATION, GENETIC; SUBSTANCE ABUSE, INTRAVENOUS; TAIWAN;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 74849128651     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21658     Document Type: Article

References (46)

1. Alter MJ. 2007. Epidemiology of hepatitis C virus infection. World J Gastroenterol 13:2436-2441.
2. Bouchardeau F, Cantaloube JF, Chevaliez S, PortalC,Razer A, Lefrere JJ, Pawlotsky JM, De MP, Laperche S. 2007. Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay. J Clin Microbiol 45:1140-1145.
3. CDC. 2006. Center for Disease Control,ROC(Taiwan).HIV/AIDS data. Available at: http://www.cdc.gov.tw/en/indexasp. Accessed 9 May.
4. Chen YM, Kuo SH. 2007. HIV-1 in Taiwan. Lancet 369:623-625.
5. Chen YM, Lan YC, Lai SF, Yang JY, Tsai SF, Kuo SH. 2006. HIV-1 CRF07-BC infections, injecting drug users, Taiwan. Emerg Infect Dis 12:703-705.
6. Chinchai T, Labout J, Noppornpanth S, Theamboonlers A, Haagmans BL, Osterhaus AD, Poovorawan Y. 2003. Comparative study of different methods to genotype hepatitis C virus type 6 variants. J Virol Methods 109:195-201.
7. CochraneA, Searle B, HardieA,Robertson R, Delahooke T, Cameron S, Tedder RS, Dusheiko GM, De Lamballerie X, Simmonds P. 2002. A genetic analysis of hepatitis Cvirus transmission between injection drug users. J Infect Dis 186:1212-1221.
8. Colina R, Casane D, Vasquez S, Garcia-Aguirre L, Chunga A, Romero H, Khan B, Cristina J. 2004. Evidence of intratypic recombination in natural populations of hepatitis C virus. J Gen Virol 85:31-37.
9. Cristina J, Colina R. 2006. Evidence of structural genomic region recombination in Hepatitis C virus. Virol J 3:53.
10. Garten RJ,Lai S, Zhang J, LiuW,Chen J,Vlahov D,YuXF. 2004.Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol 33:182-188.
11. Garten RJ, Zhang J, Lai S, Liu W, Chen J, Yu XF. 2005. Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Clin Infect Dis 41:S18-S24.
12. Garten RJ, Lai SH, Zhang JB, Liu W, Chen J, Yu XF. 2008. Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern China. World J Gastroenterol 14:1878-1884.
13. Gerberding JL. 2003. Clinical practice. Occupational exposure to HIV in health care settings. N Engl J Med 348:826-833.
14. Giannini C, Giannelli F, Monti M, Careccia G, Marrocchi ME, Laffi G, Gentilini P, Zignego AL. 1999. Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease. J Lab Clin Med 134:68-73.
15. Inoue Y, Sulaiman HA, Matsubayashi K, Iinuma K, Iinuma K, Ansari A, Laras K, Corwin AL. 2000. Genotypic analysis of hepatitis C virus in blood donors in Indonesia. Am J Trop Med Hyg 62:92-98.
16. Kageyama S, Agdamag DM, Alesna ET, Leano PS, Heredia AM, bellanosa-Tac-An IP, Jereza LD, Tanimoto T, Yamamura J, Ichimura H. 2006. A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J Med Virol 78:1423-1428.
17. Kalinina O, Norder H, Mukomolov S, Magnius LO. 2002. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 76:4034-4043.
18. Kao JH, Chen PJ, Lai MY, Yang PM, Sheu JC, Wang TH, Chen DS. 1995. Genotypes of hepatitis C virus in Taiwan and the progression of liver disease. J Clin Gastroenterol 21:233-237.
19. Kumar S, Tamura K, Nei M. 2004. MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5:150-163.
20. Legrand-Abravanel F, Claudinon J, Nicot F, Dubois M, Chapuy-Regaud S, Sandres-Saune K, Pasquier C, Izopet J. 2007. New natural intergenotypic (2/5) recombinant of hepatitis C virus. J Virol 81:4357-4362.
21. Li C, Fu Y, Lu L, Ji W, Yu J, Hagedorn CH, Zhang L. 2006. Complete genomic sequences for hepatitis C virus subtypes 6e and 6g isolated from Chinese patients with injection drug use and HIV-1 coinfection. J Med Virol 12:1061-1069.
22. Lin YT, Lan YC, Chen YJ, Huang YH, Lee CM, Liu TT, Wong WW, Yang JY, Wang CT, Chen YM. 2007. Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07-BC strains from injection drug users in Taiwan. J Infect Dis 195:11283-11293.
23. Liu JY, Lin HH, Liu YC, Lee SS, Chen YL, Hung CC, Ko WC, Huang CK, Lai CH, Chen YS, Shih YL, Chung HC, Liang SH, Lin JN. 2008. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan. Clin Infect Dis 46:1761-1768.
24. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, Ingersoll R, Sheppard HW, Ray SC. 1999. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73:152-160.
25. Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, Robertson BH. 2005. Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol 75:538-549.
26. Moreau I, Hegarty S, Levis J, Sheehy P, Crosbie O, Kenny-Walsh E, Fanning LJ. 2006. Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland. Virol J 3:95.
27. Morice Y, Cantaloube JF, Beaucourt S, Barbotte L, De Gendt S, Goncales FL, Butterworth L, Cooksley G, Gish RG, Beaugrand M, Fay F, Fay O, Gonzalez JE, Martins RM, Dhumeaux D, Vanderborght B, Stuyver L, Sablon E, de L X, Pawlotsky JM. 2006. Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J Med Virol 78:1296-1303.
28. Noppornpanth S, Lien TX, Poovorawan Y, Smits SL, Osterhaus AD, Haagmans BL. 2006a. Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol 80:7569-7577.
29. Noppornpanth S, Sablon E, De Nys K, Truong XL, Brouwer J, Van BM, Smits SL, Poovorawan Y, Osterhaus AD, Haagmans BL. 2006b. Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5' untranslated regions. J Clin Microbiol 44:3969-3974.
30. OhnoO, MizokamiM,Wu RR, Saleh MG, Ohba K, OritoE, Mukaide M, Williams R, Lau JY. 1997. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 35:201-207.
31. Piyasirisilp S, McCutchan FE, Carr JK, Sanders-Buell E, Liu W, Chen J,Wagner R,Wolf H, Shao Y, Lai S, Beyrer C, Yu XF. 2000. A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol 74:11286-11295.
32. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. 2000. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182:698-707.
33. Retief JD. 2000. Phylogenetic analysis using PHYLIP. Methods Mol Biol 132:243-258.
34. Roulot D, Bourcier V, Grando V, Deny P, Baazia Y, Fontaine H, Bailly F, Castera L, De Ledinghen V, Marcellin P, Poupon R, Bourliere M, Zarski JP, Roudot-Thoraval F. 2007. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection. J Viral Hepat 14:460-467.
35. Simmonds P. 2004. Genetic diversity and evolution of hepatitis C virus-15 years on. J Gen Virol 85:3173-3188.
36. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin I, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
37. Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, Kung HF, Lee SS. 2008. Molecular epidemiology of HCV monoinfection andHIV/HCV coinfection in injection drug users in Liuzhou, Southern China. PLoS ONE 3:e3608.
38. Tee KK,Pybus OG,Liao H, UenishiR, Hase S, Kamarulzaman A, Li XJ, Takebe Y. 2008a. Chronology of the HIV-1 CRF07-BC expansion in East Asia. AIDS 22:156-158.
39. Tee KK, Pybus OG, Li XJ, Han X, Shang H, Kamarulzaman A, Takebe Y. 2008b. Temporal and spatial dynamics of human immunodefi-ciency virus type 1 circulating recombinant forms 08-BC and 07-BC in Asia. J Virol 82:9206-9215.
40. Timm J, Neukamm M, Kuntzen T, Kim AY, Chung RT, Brander C, Lauer GM, Walker BD, Allen TM. 2007. Characterization of fulllength hepatitis C virus genotype 4 sequences. J Viral Hepat 14: 330-337.
41. Toyoda H, Fukuda Y, Hayakawa T, Kumada T, Nakano S, Takamatsu J, Saito H. 1999. Presence of multiple genotype-specific antibodies in patients with persistent infection with hepatitis C virus (HCV) of a single genotype: evidence for transient or occult superinfection with HCV of different genotypes. Am J Gastroenterol 94:2230-2236.
42. Wang Y, Xia X, Li C, Maneekarn N, Xia W, ZhaoW, Feng Y, Kung HF, Fu Y, Lu L. 2009. AnewHCVgenotype 6 subtype designated 6vwas confirmed with three complete genome sequences. J Clin Virol 44: 195-199.
43. Watson JP, Brind AM, Chapman CE, Bates CL, Gould FK, Johnson SJ, Burt AD, Ferguson J,Simmonds P, Bassendine MF. 1996. Hepatitis C virus: Epidemiology and genotypes in the north east of England. Gut 38:269-276.
44. Wu CH, Lee MF, Kuo HS. 1997. Distribution of hepatitis C virus genotypes among blood donors in Taiwan. J Gastroenterol Hepatol 12:625-628.
45. Xia X, Lu L, Tee KK, Zhao W, Wu J, Yu J, Li X, Lin Y, Mukhtar MM, Hagedorn CH, Takebe Y. 2008. The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China. J Med Virol 80:1142-1152.
46. Zhou DX, Tang JW, Chu IM, Cheung JL, Tang NL, Tam JS, Chan PK. 2006. Hepatitis C virus genotype distribution among intravenous drug user and the general population in Hong Kong. J Med Virol 78:574-581.